IQVIA Holdings (IQV) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US46266C1053
IQVIA Holdings Inc., trading under the ticker symbol IQV on the New York Stock Exchange, is a multinational company that specializes in providing cutting-edge analytics, technological solutions, and clinical research services to the life sciences sector globally, including the Americas, Europe, Africa, and the Asia-Pacific region.
The company operates through three key segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions division offers cloud-based applications, real-world solutions, strategic consulting services, and country-level performance metrics related to pharmaceutical sales and medical treatment across various channels.
The Research & Development Solutions segment focuses on project management, clinical monitoring, decentralized clinical trials, central laboratory services, genomic research, and vaccine laboratory services, among others. Meanwhile, the Contract Sales & Medical Solutions division provides health care engagement services and scientific strategy services to pharmaceutical, biotechnology, device and diagnostic, and consumer health companies.
IQVIA Holdings Inc. has a rich history, having been incorporated in 2016 and known previously as Quintiles IMS Holdings, Inc. The company's headquarters are located in Durham, North Carolina. They have established a strong online presence through their website at https://www.iqvia.com.
As a leader in the life sciences industry, IQVIA Holdings Inc. continues to drive innovation and transformation through its comprehensive range of services, collaborating with global partners like argenx SE to deliver impactful solutions that enhance healthcare decision-making and ultimately improve patient outcomes.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
IQV Stock Overview
Market Cap in USD | 43,323m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 2013-05-09 |
IQV Stock Ratings
Growth 5y | 4.60 |
Fundamental | 29.0 |
Dividend | - |
Rel. Performance vs Sector | 1.25 |
Analysts | 4.41/5 |
Fair Price Momentum | 228.85 USD |
Fair Price DCF | 230.48 USD |
IQV Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
IQV Growth Ratios
Growth 12m | 26.77% |
Growth Correlation 12m | 40% |
Growth Correlation 3m | 17% |
CAGR 5y | 11.59% |
Sharpe Ratio 12m | 0.81 |
Alpha vs SP500 12m | -9.21 |
Beta vs SP500 5y weekly | 1.42 |
ValueRay RSI | 53.23 |
Volatility GJR Garch 1y | 26.83% |
Price / SMA 50 | -1.63% |
Price / SMA 200 | 9.4% |
Current Volume | 1505.7k |
Average Volume 20d | 784.8k |
External Links for IQV Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 25, 2024, the stock is trading at USD 240.84 with a total of 1,505,728 shares traded.
Over the past week, the price has changed by +5.98%, over one month by -3.23%, over three months by +13.13% and over the past year by +18.65%.
According to ValueRays Forecast Model, IQV IQVIA Holdings will be worth about 254.1 in April 2025. The stock is currently trading at 240.84. This means that the stock has a potential upside of +5.48%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 275.8 | 14.5 |
Analysts Target Price | 247.2 | 2.65 |
ValueRay Target Price | 254.1 | 5.48 |